Director Dealings

Transactions

Dealing dateCompany / TickerName / TitleSharesPer shareDeal size
Purchase06 Feb 2026Roper Technologies IncROP:NSQThomas P. JoyceIndependent Director1,400358.46 USD501.84k USD
Sale06 Feb 2026Broadridge Financial Solutions IncBR:NYQRobert N. DuelksIndependent Director253192.60 USD48.73k USD
Sale05 Feb 2026Teradyne IncTER:NSQMercedes JohnsonIndependent Director625266.98 USD166.86k USD
Sale05 Feb 2026Ziprecruiter IncZIP:NYQIan SiegelChief Executive Officer and Chairman of the Board9,7221.97 USD19.15k USD
Purchase05 Feb 2026United Utilities Group PLCUU.:LSEMarina M WyattNon-Executive Director2,40012.69 GBP30.47k GBP
Sale05 Feb 2026Merchants BancorpMBIN:NAQMichael F. PetrieChief Executive Officer; Chairman of the Board of the Company and Merchants Bank of Indiana2,03420.20 USD41.09k USD
Purchase05 Feb 2026Arcontech Group PLCARC:LSEMatthew David JeffsExecutive Director,Chief Executive Officer20,0000.7646 GBP15.29k GBP
Sale05 Feb 2026Waterstone Financial IncWSBF:NSQDouglas S. GordonDirector18,71618.25 USD341.57k USD
Sale05 Feb 2026East West Bancorp IncEWBC:NSQJack C. LiuIndependent Director1,421119.00 USD169.10k USD
Sale05 Feb 2026Halozyme Therapeutics IncHALO:NSQHelen I. TorleyDirector, President and Chief Executive Officer5,37678.38 USD421.37k USD
Sale05 Feb 2026Halozyme Therapeutics IncHALO:NSQHelen I. TorleyDirector, President and Chief Executive Officer4,62478.94 USD365.00k USD
Purchase05 Feb 2026Veradermics IncMANE:NYQPatrick G. EnrightIndependent Director192,64717.00 USD3.27m USD
Purchase05 Feb 2026Veradermics IncMANE:NYQPatrick G. EnrightIndependent Director882,35317.00 USD15.00m USD
Purchase05 Feb 2026Veradermics IncMANE:NYQJohn W. ChildsIndependent Director294,11717.00 USD5.00m USD
Purchase05 Feb 2026Veradermics IncMANE:NYQVlad CoricIndependent Director58,82317.00 USD999.99k USD
23133 total results
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.
www.morningstar.com